维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Sorror"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities显示文摘	Hesham Eissa Ted A. Gooley Mohamed L. Sorror Franchesca Nguyen Bart L. Scott Kristine Doney Keith R. Loeb Paul J. Martin John M. Pagel Jerry P. Radich Brenda M. Sandmaier E. Houston Warren Rainer Storb Frederick R. Appelbaum H. Joachim Deeg	2011	Biology of Blood and Marrow Transplantation2011，，：	2
2	Frequency of Allogeneic Hematopoietic Cell Transplantation Among Patients With High- or Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission显示文摘	Raya Mawad Ted A. Gooley Vicky Sandhu Jack Lionberger Bart Scott Brenda M. Sandmaier Paul O’Donnell Pamela S. Becker Stephen Petersdorf Kathleen Shannon Dorcy Paul Hendrie Mohamed L. Sorror Roland B. Walter H. Joachim Deeg Frederick R. Appelbaum Elihu H.	2013	Journal of Clinical Oncology2013，，31：	1
3	Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies显示文摘	Nemecek ER Guthrie KA Sorror ML		0，，03：	1
4	Hematopoietic cell transplantation (HCT)-specific comorbidity index:a new tool for risk assessment before allogeneic HCT显示文摘	Sorror M L Maris M B Storb R	2005	Blood2005，106，：	1
5	Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission:combined FHCRC and MDACC experiences显示文摘	Sorror ML Giralt S Sandmaier BM	2007	Blood2007，110，13：	1
6	Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies显示文摘	Nemecek ER Guthrie KA Sorror ML	2011	Biol Blood Marrow Transplant2011，17，3：	1
7	Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission:combined FHCRC and MDACC experiences显示文摘	Sorror ML Giralt S Sandmaier BM	2007	Blood2007，110，：	1
8	Five-year followup of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning显示文摘	SORROR M L STORER B E SANDMAIER B M	2008	J Clin Oncol2008，26，：	1
9	Cornorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation 显示文摘	Sorror ML Sandmaier BM Storer BE	2007	J Clin Oncol2007，25，：	1
10	Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with al- Iogeneic hematopoietic cell transplantation after nonmyeloablative conditioning显示文摘	Sorror ML Storer BE Sandmaier BM	2008	J Clin Oncol2008，26，30：	1
11	Pre-transplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality 显示文摘	Sorror ML Martin P J Storb RF	2014	Blood2014，124，2：	1
12	The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation显示文摘	WANG Z SORROR ML LEISENRING W	2010	Br J Haema- tol2010，149，：	1
13	Hematopoietic cell transplantation(HCT)-specific comorbidity index:a new tool for risk assessment before allogeneic HCT显示文摘	Sorror ML Maris MB Storb R	2005	Blood2005，106，8：	1
14	Outcomes after alloge-neic hematopoietic cell transplantation with nonmyeloablative or mye-loablative conditioning regimens for treatment of lymphoma and chron-ic lymphocytic leukemia 显示文摘	Sorror M L Storer B E Maloney D G ei al	2008	Blood2008，111，1：	1
15	Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia显示文摘	Sorror ML Maris MB Sandmaier BM	2005	J Clin Oncol2005，23，16：	1
16	Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia:relapse-free survival is determined by karyotype and comorbidities显示文摘	Eissa H Gooley TA Sorror ML	2011	Biol Blood Marrow Transplant2011，17，6：	1
17	Hematopoietic cell trans- plantation (HCT)- specific comorbidity index:a new tool for risk assessment before allogeneic HCT显示文摘	Sorror ML Maris MB Storb R	2005	Blood2005，106，8：	1
18	Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT 显示文摘	Sorror M L Maris M B Storb R	2005	Blood2005，106，8：	1
19	The dynamic international prognostic scoring system for myelofibro- sis predicts outcomes after hematopoietic cell trans- plantation显示文摘	Scott BL Gooley TA Sorror ML	2012	Blood2012，119，：	1
20	The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation显示文摘	Wang Z Sorror ML Leisenring W	2010	Br J Haematol2010，149，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示